PSMA targeting CAR T cell immunotherapeutic strategy for prostate cancer.

被引：0
|
作者：
Gonzalez-Valdivieso, Juan [1 ]
Yang, Yanping [1 ]
Vedvyas, Yogindra [1 ]
Alcaina, Yago [1 ]
Jin, Moonsoo M. [1 ]
机构：
[1] Weill Cornell Med, New York, NY USA
来源：
CANCER RESEARCH | 2022年 / 82卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5577
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Evaluation of an immunotherapeutic DNA-vaccine in biochemically relapsed prostate cancer.
    Shore, Neal D.
    Heath, Elisabeth I.
    Nordquist, Luke T.
    Cheng, Heather H.
    Bhatt, Kamalnayan
    Morrow, Matthew
    McMullan, Trevor
    Kraynyak, Kimberly
    Lee, Jessica
    Sacchetta, Brian
    Liu, Li
    Rosencranz, Samantha
    Tagawa, Scott T.
    Parikh, Rahul Atul
    Tutrone, Ronald F.
    Garcia, Jorge A.
    Whang, Young E.
    Kelly, William Kevin
    Csiki, Ildiko
    Bagarazzi, Mark L.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [32] TARGETING T CELL FATES: CONVERTING EXHAUSTION TO MEMORY TO IMPROVE IMMUNOTHERAPEUTIC RESPONSES TO CANCER
    Scharping, Nicole
    Cafferata, Allison
    Heeg, Maximilian
    Quynhanh Nguyen
    Goldrath, Ananda
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A688 - A688
  • [33] Selective tumor infarction induced with vascular specific thrombogen targeting PSMA accessible in the tumor vasculature in prostate cancer.
    Liu, C
    Huang, H
    Donate, F
    Dickinson, C
    Santucci, R
    El Sheikh, A
    Edgington, TS
    CLINICAL CANCER RESEARCH, 2001, 7 (11) : 3655S - 3655S
  • [34] Evaluation of a Long-circulating PSMA-targeting Peptide in a Xenograft Model of Bone Metastatic Prostate Cancer.
    Lo, W.
    Huang, Y.
    Chen, M.
    Lu, A.
    Wang, S.
    Chen, L.
    Farn, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S442 - S442
  • [35] Beyond CAR T Cells: Other Cell-Based Immunotherapeutic Strategies Against Cancer
    Patel, Shabnum
    Burga, Rachel A.
    Powell, Allison B.
    Chorvinsky, Elizabeth A.
    Hoq, Nia
    McCormack, Sarah E.
    Van Pelt, Stacey N.
    Hanley, Patrick J.
    Cruz, Conrad Russell Y.
    FRONTIERS IN ONCOLOGY, 2019, 9
  • [36] Dynamic SPECT imaging of PSMA-specific CAR T cells in mice bearing prostate cancer
    Emami-Shahri, Nia
    Foster, Julie
    Sosabowski, Jane
    Maher, John
    Papa, Sophie
    CANCER RESEARCH, 2016, 76
  • [37] Chimeric antigen receptor (CAR+) modified T cells targeting prostate-specific membrane antigen (PSMA) in patients (pts) with castrate metastatic prostate cancer (CMPC)
    Slovin, Susan F.
    Wang, Xiuyan
    Hullings, Melanie
    Arauz, Gabrielle
    Bartido, Shirley
    Lewis, Jason Stuart
    Schoeder, Heiko
    Zanzonico, Pat
    Scher, Howard I.
    Sadelain, Michel
    Riviere, Isabelle
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)
  • [38] A phase I clinical trial of PSMA-directed/TGF[beta]-insensitive CAR-T cells in metastatic castration-resistant prostate cancer.
    Narayan, Vivek
    Barber-Rotenberg, Julie
    Fraietta, Joseph
    Hwang, Wei-Ting
    Lacey, Simon F.
    Plesa, Gabriela
    Carpenter, Erica L.
    Maude, Shannon L.
    Lal, Priti
    Vapiwala, Neha
    Melenhorst, Jan J.
    Sebro, Ronnie
    Farwell, Michael
    Moniak, Michael
    Gilmore, Joan
    Lledo, Lester
    Dengel, Karen
    June, Carl H.
    Haas, Naomi B.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [39] Targeting cell-adaptive mechanisms of drug resistance in lethal prostate cancer.
    Subramaniam, Prem
    Vasciaveo, Alessandro
    Arriaga, Juan
    Kesner, Jordan
    Abate-Shen, Cory
    Califano, Andrea
    CANCER RESEARCH, 2021, 81 (13)
  • [40] Why Targeting PSMA Is a Game Changer in the Management of Prostate Cancer
    Donin, Nicholas M.
    Reiter, Robert E.
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59 (02) : 177 - 182
12345